Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$2.04 USD
-0.01 (-0.49%)
Updated Sep 12, 2024 03:56 PM ET
4-Sell of 5 4
B Value C Growth F Momentum B VGM
Brokerage Reports
Ayr Wellness Inc. [AYRWF]
Reports for Purchase
Showing records 21 - 40 ( 98 total )
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
3Q23 Weak Guides Lower, Debt Extended to ''26 Provides Runway, PT $3.50
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: Ohio Becomes 24th Adult-Use State
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Addresses Balance Sheet With Needed NT Extensions
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: October 2023 Performance Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Declining Prices Drives Volume + Illicit Conversion
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Valuation Expectations Framework
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Monumental ReScheduling Signals U.S. Cannabis Normalization
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: 2Q23 Takeaways, Ops Right-sizing + Efficiencies Offset Pricing
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
2Q23 Margin Gains with Expansion in 2H23 to Drive OCF
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
1Q23 Solid, Ops Progress Leading to Margin Expansion OCF
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Earnings Week II
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Amends Two Earn-Out Agreements, Alleviates NT Overhang Balance Sheet
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: April 2023 Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S